Lv4
510 积分 2023-06-28 加入
Clopidogrel versus Ticagrelor in CYP2C19 Loss-of-Function Allele Noncarriers: A Real-World Study in China
3天前
已完结
Safety and Efficacy of CYP2C19 Genotype-Guided Escalation of P2Y12 Inhibitor Therapy After Percutaneous Coronary Intervention in Chronic Kidney Disease: a Post Hoc Analysis of the TAILOR-PCI Study
3天前
已完结
Pharmacogenetics of P2Y 12 receptor inhibitors
3天前
已完结
Antiplatelet therapy in high-bleeding risk patients with acute coronary syndrome: pharmacogenomics in the era of precision medicine
3天前
待确认
Pharmacogenetics of P2Y 12 receptor inhibitors
3天前
已完结
Effect of Genotype-Guided Oral P2Y12 Inhibitor Selection vs Conventional Clopidogrel Therapy on Ischemic Outcomes After Percutaneous Coronary Intervention
3天前
已完结
Genotype-Guided P2Y 12 -Inhibitor De-Escalation Strategy in Acute Coronary Syndrome: Observational Evidence From the POPular-GUIDE PCI
5天前
已完结
The Clinical Implementation of CYP2C19 Genotyping in Patients with an Acute Coronary Syndrome: Insights From the FORCE-ACS Registry
5天前
已完结
Effect of CYP2C19 Genotype on Outcomes of Treatment with Ticagrelor versus Clopidogrel in Acute Coronary Syndrome Patients with Diabetes Mellitus: A Analysis in a Large-Scale, Real-World Study
5天前
已完结
Point of care CYP2C19 genotyping after percutaneous coronary intervention
5天前
已完结
皖公网安备34019202002308
